Te. Bunton, INTERMEDIATE FILAMENT REACTIVITY IN HYPERPLASTIC AND NEOPLASTIC LESIONS FROM MEDAKA (ORYZIAS-LATIPES), Experimental and toxicologic pathology, 46(4-5), 1994, pp. 389-396
To determine if hyperplastic and neoplastic lesions from medaka showed
similar immunoreactivity to intermediate filament antibodies as the t
issues of origin, two week old medaka were exposed to 10 or 20 mg/L of
methylazoxymethanol acetate for two hours and transferred to clean wa
ter for up to six months. Using a streptavidin peroxidase method, para
ffin embedded Bouins fixed neoplasms were incubated with cytokeratin,
vimentin, or neurofilament antibodies. Like their nonneoplastic cellul
ar counterparts, hepatocellular carcinoma, pancreatic acinar carcinoma
and mesenchymal neoplasms including hemangioma and hemangiopericytoma
reacted negatively to cytokeratin antibodies. Cholangiocarcinoma, mes
othelioma, and proliferative lesions containing biliary epithelial cel
ls reacted positively to cytokeratin antibodies. All neoplasms and pro
liferative lesions were negative with vimentin and neurofilament antib
odies. These data indicate that while some epithelial neoplasms showed
cytokeratin reactivity similar to the parent tissues, additional mark
ers are needed to identify mesenchymal tissues and neoplasms.